Overview
James Ingle is an Oncologist in Rochester, Minnesota. Dr. Ingle is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Menopause, and HER-2 Positive Breast Cancer.
His clinical research consists of co-authoring 179 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of HER-2 Positive Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Minetta Liu is an Oncologist and a Hematologist Oncology provider in Rochester, Minnesota. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, Virilizing Ovarian Tumor, and Percutaneous Coronary Intervention (PCI).
Mayo Clinic
Timothy Hobday is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Hobday is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Embryonal Tumor with Multilayered Rosettes, Pancreatic Cancer, and Liver Embolization.
Mayo Clinic
Matthew Block is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Block is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Melanoma, Ovarian Cancer, Endometrial Cancer, and Ovarian Carcinosarcoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Ingle isElite. Learn about Breast Cancer.
- Triple-Negative Breast Cancer
- Distinguished
- MenopauseDr. Ingle isDistinguished. Learn about Menopause.
- Advanced
- HER-2 Positive Breast CancerDr. Ingle isAdvanced. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Ingle isAdvanced. Learn about HER2 Negative Breast Cancer.
- Experienced
- Teratoma of the MediastinumDr. Ingle isExperienced. Learn about Teratoma of the Mediastinum.